8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Challenges Facing Radiation Oncologists in The Management of Older Cancer Patients: Consensus of The International Geriatric Radiotherapy Group

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The management of older cancer patients remains difficult because of data paucity. Radiation oncologists need to identify potential issues which could affect treatment of those patients. A workshop was organized in Barcelona among international radiation oncologists with special interest in the management of older cancer patients on April 22, 2018. The following consensus was reached: 1. Older cancer patients often faced unconscious discriminating bias from cancer specialists and institutions because of their chronological age. 2. Advances in radiotherapy techniques have allowed patients with multiple co-morbidities precluding surgery or systemic therapy to achieve potential cure in early disease stages. 3. The lack of biomarkers for frailty remains an impediment to future research. 4. Access to healthcare insurance and daily transportation remains an issue in many countries; 5. Hypofractionation, brachytherapy, or stereotactic techniques may be ideally suited for older cancer patients to minimize transportation issues and to improve tolerance to radiotherapy. 6. Patients with locally advanced disease who are mentally and physically fit should receive combined therapy for potential cure. 7. The role of systemic therapy alone or combined with radiotherapy for frail patients needs to be defined in future clinical trials because of targeted agents or immunotherapy may be less toxic compared to conventional chemotherapy.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          American Cancer Society lung cancer screening guidelines.

          Findings from the National Cancer Institute's National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can be reduced by annual screening with low-dose computed tomography. These findings indicate that the adoption of lung cancer screening could save many lives. Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening. This guideline recommends that clinicians with access to high-volume, high-quality lung cancer screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years. A process of informed and shared decision-making with a clinician related to the potential benefits, limitations, and harms associated with screening for lung cancer with low-dose computed tomography should occur before any decision is made to initiate lung cancer screening. Smoking cessation counseling remains a high priority for clinical attention in discussions with current smokers, who should be informed of their continuing risk of lung cancer. Screening should not be viewed as an alternative to smoking cessation. Copyright © 2013 American Cancer Society, Inc.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Renal Aging: Causes and Consequences.

            Individuals age >65 years old are the fastest expanding population demographic throughout the developed world. Consequently, more aged patients than before are receiving diagnoses of impaired renal function and nephrosclerosis-age-associated histologic changes in the kidneys. Recent studies have shown that the aged kidney undergoes a range of structural changes and has altered transcriptomic, hemodynamic, and physiologic behavior at rest and in response to renal insults. These changes impair the ability of the kidney to withstand and recover from injury, contributing to the high susceptibility of the aged population to AKI and their increased propensity to develop subsequent progressive CKD. In this review, we examine these features of the aged kidney and explore the various validated and putative pathways contributing to the changes observed with aging in both experimental animal models and humans. We also discuss the potential for additional study to increase understanding of the aged kidney and lead to novel therapeutic strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.

              Answer questions and earn CME/CNE The concept of frailty has become increasingly recognized as one of the most important issues in health care and health outcomes and is of particular importance in patients with cancer who are receiving treatment with surgery, chemotherapy, and radiotherapy. Because both cancer itself, as well as the therapies offered, can be significant additional stressors that challenge a patient's physiologic reserve, the incidence of frailty in older patients with cancer is especially high-it is estimated that over one-half of older patients with cancer have frailty or prefrailty. Defining frailty can be challenging, however. Put simply, frailty is a state of extreme vulnerability to stressors that leads to adverse health outcomes. In reality, frailty is a complex, multidimensional, and cyclical state of diminished physiologic reserve that results in decreased resiliency and adaptive capacity and increased vulnerability to stressors. In addition, over 70 different measures of frailty have been proposed. Still, it has been demonstrated that frail patients are at increased risk of postoperative complications, chemotherapy intolerance, disease progression, and death. Although international standardization of frailty cutoff points are needed, continued efforts by oncology physicians and surgeons to identify frailty and promote multidisciplinary decision making will help to develop more individualized management strategies and optimize care for patients with cancer. CA Cancer J Clin 2017;67:362-377. © 2017 American Cancer Society.
                Bookmark

                Author and article information

                Journal
                Cancers (Basel)
                Cancers (Basel)
                cancers
                Cancers
                MDPI
                2072-6694
                16 March 2019
                March 2019
                : 11
                : 3
                : 371
                Affiliations
                [1 ]Department of Radiation Oncology, Prof. Dr. Ion Chricuta Oncology Institute, Cluj-Napoca 400015, Romania; tiberiu_popescu14@ 123456yahoo.com
                [2 ]Department of Radiation Oncology, International Geriatric Radiotherapy Group, Washington, DC 20001, USA; karlssonulf30@ 123456gmail.com
                [3 ]Department of Radiation Oncology, University Hospital of Martinique, Martinique 97200, France; anhxang@ 123456gmail.com
                [4 ]Department of Radiation Oncology, Instituto Portugues de Oncologia Francisco Martins Porto E.P.E, Porto 4200-072, Portugal; lurdes.trigo@ 123456ipoporto.min-saude.pt
                [5 ]Department of Radiation Oncology, Baclesse Cancer Center, Caen 14000, France; jthariat@ 123456gmail.com
                [6 ]Department of Radiation Oncology, McGill University, Montreal H3T 1E2, Canada; te.vuong@ 123456mcgill.ca
                [7 ]Department of Radiation Oncology, University of Bonn, Bonn 43217, Germany; brigitta.baumert@ 123456gmail.com
                [8 ]Department of Radiation Oncology, Humanitas Gavazzeni Bergamo, Bergamo 24125, Italy; motta.micaela@ 123456libero.it
                [9 ]Radiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine, Sant’Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy; alice.zamagni4@ 123456unibo.it
                [10 ]Department of Radiation Oncology, Arnau de Vilanova University Hospital, Lleida 25198, Spain; bonet.marta@ 123456gmail.com
                [11 ]Department of Radiation Oncology, Clattterbridge Cancer Center, Liverpool CH63 4JY, UK; sun.myint@ 123456nhs.net
                [12 ]Department of Radiation Oncology, Fernando Pessoa Canarias Las Palmas University, Las Palmas 35010, Spain; pedrocarlos.lara@ 123456ulpgc.es
                [13 ]Department of Radiation Oncology, Howard University, Washington, DC 20060, USA
                [14 ]Department of Radiation Oncology, Sant Joan de Reus University, University Rovira i Virgili, Tarragona 43204, Spain; meritxell.arenas@ 123456gmail.com
                Author notes
                [* ]Correspondence: namphong.nguyen@ 123456yahoo.com ; Tel.: +1-202-865-1714; Fax: +1-202-806-7934
                Author information
                https://orcid.org/0000-0002-6403-6120
                https://orcid.org/0000-0001-5106-6665
                Article
                cancers-11-00371
                10.3390/cancers11030371
                6468336
                30884827
                4f435f3e-57cc-40cc-ac6c-7f4202c0f753
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 06 February 2019
                : 08 March 2019
                Categories
                Perspective

                older,discrimination,frailty,comorbidity,radiotherapy tolerance

                Comments

                Comment on this article